Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of ROFLUMILAST on Markers of Subclinical Atherosclerosis In Stable COPD; the ELASTIC-trial

NCT01630200 is registered in ClinicalTrials.gov with LudwLudwig Boltzmann Institute for COPD and Respiratory Epidemiology as lead sponsor.

NCT NCT01630200
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01630200 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of ROFLUMILAST on Markers of Subclinical Atherosclerosis In Stable COPD; the ELASTIC-trial
Lead sponsor
LudwLudwig Boltzmann Institute for COPD and Respiratory Epidemiology
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2012
Completion date
January 31, 2016
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease and allied conditions